Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

The SURPASS study is enrolling patients at research sites across the U.S. and EuropeELA026 targets signal regulatory proteins (SIRP) as a novel ...

Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers

IND opening marks culmination of partnership between Dewpoint and Evotec, advancing a de novo development candidate through IND-enabling studies ...
Ophthalmology Times

The mechanics of presbyopia: From muscle movement to functional vision

Functional vision improvements are reported, with optimal pupil size considerations for varying light conditions being ...
AHA/ASA Journals

First Aid: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations

The International Liaison Committee on Resuscitation conducts continuous reviews of new, peer-reviewed, published first aid ...

Incyte Corporation (INCY) Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic Cancer Transcript

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...